| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1687 | 2020 |
| Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas Q Deng, G Han, N Puebla-Osorio, MCJ Ma, P Strati, B Chasen, E Dai, ... Nature medicine 26 (12), 1878-1887, 2020 | 377 | 2020 |
| Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma L Zhang, Y Yao, S Zhang, Y Liu, H Guo, M Ahmed, T Bell, H Zhang, G Han, ... Science translational medicine 11 (491), eaau1167, 2019 | 207 | 2019 |
| iTALK: an R package to characterize and illustrate intercellular communication Y Wang, R Wang, S Zhang, S Song, C Jiang, G Han, M Wang, J Ajani, ... BioRxiv, 507871, 2019 | 207 | 2019 |
| Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma R Wang, M Dang, K Harada, G Han, F Wang, M Pool Pizzi, M Zhao, ... Nature medicine 27 (1), 141-151, 2021 | 158 | 2021 |
| Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response R Wang, S Song, K Harada, FG Amlashi, B Badgwell, MP Pizzi, Y Xu, ... Gut 69 (1), 18-31, 2020 | 127 | 2020 |
| CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel V Plaks, JM Rossi, J Chou, L Wang, S Poddar, G Han, Z Wang, SQ Kuang, ... Blood, The Journal of the American Society of Hematology 138 (12), 1081-1085, 2021 | 105 | 2021 |
| 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy G Han, G Yang, D Hao, Y Lu, K Thein, BS Simpson, J Chen, R Sun, ... Nature communications 12 (1), 5606, 2021 | 99 | 2021 |
| Concerted perturbation observed in a hub network in Alzheimer’s disease D Liang, G Han, X Feng, J Sun, Y Duan, H Lei PloS one 7 (7), e40498, 2012 | 83 | 2012 |
| Resolving the spatial and cellular architecture of lung adenocarcinoma by multiregion single-cell sequencing A Sinjab, G Han, W Treekitkarnmongkol, K Hara, PM Brennan, M Dang, ... Cancer discovery 11 (10), 2506-2523, 2021 | 71 | 2021 |
| Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Y Chu, E Dai, Y Li, G Han, G Pei, DR Ingram, K Thakkar, JJ Qin, M Dang, ... Nature medicine 29 (6), 1550-1562, 2023 | 70 | 2023 |
| LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma Y Xu, Y Li, J Jin, G Han, C Sun, MP Pizzi, L Huo, A Scott, Y Wang, L Ma, ... Molecular cancer 18, 1-15, 2019 | 67 | 2019 |
| TissGDB: tissue-specific gene database in cancer P Kim, A Park, G Han, H Sun, P Jia, Z Zhao Nucleic acids research 46 (D1), D1031-D1038, 2018 | 66 | 2018 |
| Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL)‐outcomes and mutation profile from venetoclax resistant MCL patients S Zhao, R Kanagal‐Shamanna, L Navsaria, CY Ok, S Zhang, K Nomie, ... American journal of hematology 95 (6), 623-629, 2020 | 64 | 2020 |
| Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy CP Vellano, MG White, MC Andrews, M Chelvanambi, RG Witt, ... Nature 606 (7915), 797-803, 2022 | 61 | 2022 |
| Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities Z Bai, B Stamova, H Xu, BP Ander, J Wang, GC Jickling, X Zhan, DZ Liu, ... Alzheimer Disease & Associated Disorders 28 (3), 226-233, 2014 | 61 | 2014 |
| YAP1-Mediated CDK6 activation confers radiation resistance in esophageal cancer–rationale for the combination of YAP1 and CDK4/6 inhibitors in esophageal cancer F Li, Y Xu, B Liu, PK Singh, W Zhao, J Jin, G Han, AW Scott, X Dong, ... Clinical Cancer Research 25 (7), 2264-2277, 2019 | 60 | 2019 |
| Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL P Jain, S Zhang, R Kanagal-Shamanna, CY Ok, K Nomie, GN Gonzalez, ... Blood Advances 4 (6), 1038-1050, 2020 | 52 | 2020 |
| Enhancer reprogramming confers dependence on glycolysis and IGF signaling in KMT2D mutant melanoma M Maitituoheti, EZ Keung, M Tang, L Yan, H Alam, G Han, AK Singh, ... Cell reports 33 (3), 2020 | 49 | 2020 |
| Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma S Zhang, VC Jiang, G Han, D Hao, J Lian, Y Liu, R Zhang, J McIntosh, ... Nature communications 12 (1), 2877, 2021 | 45 | 2021 |
Linghua WangAssociate Professor, Genomic Medicine, MD Anderson Cancer CenterVerified email at mdanderson.org
